Role of G protein-associated membrane receptors in the pathogenesis of osteoporosis

A. Domnina, O. Krasnova, K. Kulakova, Yu. V. Sopova, V. Karelkin, O. Lesnyak, I. Neganova
{"title":"Role of G protein-associated membrane receptors in the pathogenesis of osteoporosis","authors":"A. Domnina, O. Krasnova, K. Kulakova, Yu. V. Sopova, V. Karelkin, O. Lesnyak, I. Neganova","doi":"10.18705/2311-4495-2022-9-4-41-61","DOIUrl":null,"url":null,"abstract":"Osteoporosis is a chronic disease characterized by a pathological change in bone tissue, excessive fragility and a decrease in bone strength as a result of the predominance of bone resorption processes over the process of bone formation. This disease manifests in the form of low-traumatic fractures occurring in result of falling from a height of one’s height, or with little physical exertion. Osteoporosis could result in the fractures of the vertebral bodies and bones of the peripheral skeleton, causing a high level of disability. Of note, postmenopausal osteoporosis develops in women against the background of the cessation of the menstrual cycle. Here we overview the role of G-protein-associated membrane receptors (GPCR family) in the pathogenesis of this disease and the prospects for finding targets among these receptors for the diagnosis and treatment of osteoporosis. Malformations in the genes encoding GPCR lead to impaired bone tissue remodeling. Exploring the functions of GPCR family members is critical to the search for predisposition markers of bone tissue dysfunction and could improve the early diagnosis of osteoporosis. Studies on a model of osteoblasts differentiated from hIPSCs obtained from patients with osteoporosis associated with mutations in the genes of the GPCR family will allow a deeper understanding of the molecular nature of osteoporosis and the identification of new targets for osteoporosis treatment.","PeriodicalId":89863,"journal":{"name":"Translational medicine (Sunnyvale, Calif.)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational medicine (Sunnyvale, Calif.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18705/2311-4495-2022-9-4-41-61","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Osteoporosis is a chronic disease characterized by a pathological change in bone tissue, excessive fragility and a decrease in bone strength as a result of the predominance of bone resorption processes over the process of bone formation. This disease manifests in the form of low-traumatic fractures occurring in result of falling from a height of one’s height, or with little physical exertion. Osteoporosis could result in the fractures of the vertebral bodies and bones of the peripheral skeleton, causing a high level of disability. Of note, postmenopausal osteoporosis develops in women against the background of the cessation of the menstrual cycle. Here we overview the role of G-protein-associated membrane receptors (GPCR family) in the pathogenesis of this disease and the prospects for finding targets among these receptors for the diagnosis and treatment of osteoporosis. Malformations in the genes encoding GPCR lead to impaired bone tissue remodeling. Exploring the functions of GPCR family members is critical to the search for predisposition markers of bone tissue dysfunction and could improve the early diagnosis of osteoporosis. Studies on a model of osteoblasts differentiated from hIPSCs obtained from patients with osteoporosis associated with mutations in the genes of the GPCR family will allow a deeper understanding of the molecular nature of osteoporosis and the identification of new targets for osteoporosis treatment.
G蛋白相关膜受体在骨质疏松症发病机制中的作用
骨质疏松症是一种慢性疾病,其特征是骨组织的病理变化、过度脆弱和骨强度下降,这是由于骨吸收过程比骨形成过程占主导地位。这种疾病表现为从同一高度坠落或很少体力消耗导致的低创伤性骨折。骨质疏松症可能导致椎体和外周骨骼骨折,导致高度残疾。值得注意的是,绝经后的骨质疏松症是在月经周期停止的背景下发展起来的。在此,我们概述了G蛋白相关膜受体(GPCR家族)在该疾病发病机制中的作用,以及在这些受体中寻找诊断和治疗骨质疏松症的靶点的前景。编码GPCR的基因的畸形导致骨组织重塑受损。探索GPCR家族成员的功能对于寻找骨组织功能障碍的易感性标志物至关重要,并且可以提高骨质疏松症的早期诊断。对从与GPCR家族基因突变相关的骨质疏松症患者获得的hIPSCs分化的成骨细胞模型的研究将有助于更深入地了解骨质疏松症的分子性质,并确定骨质疏松症治疗的新靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书